CIK 0001488039 · Non-accelerated filer<br>Smaller reporting company
ATOSSA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATOS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264753208
- Phone
- 206.588.0256
- Business address
- 1448 NW MARKET STREET, SUITE 500, SEATTLE, WA, 98107
- Former names
- ATOSSA GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-15 | WEAVER GREGORY L Former EVP, CFO, & Director | Sale | −50,000 | $0.65 | $33K | 55 |
| 2021-07-02 | WEAVER GREGORY L Director | Sale | −107,497 | $5.58 | $600K | 0 |
| 2013-10-01 | QUAY STEVEN C CEO | Sale | −7,265 | $5.66 | $41K | 4,268,315 |
| 2013-10-01 | Chen Shu-Chih Chief Scientific Officer | Sale | −7,265 | $5.66 | $41K | 4,268,315 |
Page 1 of 1 · 4 trades